Your browser doesn't support javascript.
loading
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
Donnelly, David W; Vis, Linda C; Kearney, Therese; Sharp, Linda; Bennett, Damien; Wilding, Sarah; Downing, Amy; Wright, Penny; Watson, Eila; Wagland, Richard; Cross, William R; Mason, Malcolm D; Siesling, Sabine; van Manen, Jeannette G; Glaser, Adam W; Gavin, Anna.
Afiliação
  • Donnelly DW; Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6DP, Northern Ireland, UK. david.donnelly@qub.ac.uk.
  • Vis LC; Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6DP, Northern Ireland, UK.
  • Kearney T; Department of Health Technology & Services Research, University of Twente, Enschede, The Netherlands.
  • Sharp L; Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6DP, Northern Ireland, UK.
  • Bennett D; Institute of Health & Society, Newcastle University, Newcastle-upon-Tyne, England.
  • Wilding S; Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6DP, Northern Ireland, UK.
  • Downing A; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, England.
  • Wright P; Leeds Institute of Data Analytics, University of Leeds, Leeds, England.
  • Watson E; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, England.
  • Wagland R; Leeds Institute of Data Analytics, University of Leeds, Leeds, England.
  • Cross WR; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, England.
  • Mason MD; Department of Midwifery, Community and Public Health, School of Nursing and Midwifery, Oxford Brookes University, Oxford, England.
  • Siesling S; Faculty of Health Sciences, University of Southampton, Southampton, England.
  • van Manen JG; Department of Urology, St James's University Hospital, Leeds, England.
  • Glaser AW; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, Wales.
  • Gavin A; Department of Health Technology & Services Research, University of Twente, Enschede, The Netherlands.
BMC Cancer ; 19(1): 947, 2019 Oct 15.
Article em En | MEDLINE | ID: mdl-31615476
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Qualidade de Vida / Antígeno Prostático Específico / Medidas de Resultados Relatados pelo Paciente / Sobreviventes de Câncer Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Qualidade de Vida / Antígeno Prostático Específico / Medidas de Resultados Relatados pelo Paciente / Sobreviventes de Câncer Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido